IRADIMED CORP Form 8-K Summary
Business Context and Reporting Period
This Form 8-K was filed by IRADIMED CORPORATION on October 28, 2016. The filing serves to announce the Company's financial results for the third quarter ended September 30, 2016. The report references a press release furnished as Exhibit 99.1 containing the detailed results.
Key Financial Metrics
The provided filing text does not contain specific numerical values for revenue, profit, cash flow, margins, debt, or liquidity. These metrics are contained within the referenced press release (Exhibit 99.1), which is not included in the input text.
Material Changes
The filing text does not provide specific data regarding material changes versus the prior comparable period. It only confirms the issuance of results for the third quarter of 2016.
Guidance, Outlook, and Risks
The filing text does not include management commentary, forward-looking guidance, specific risks, contingencies, or unusual items. The document explicitly states that the information in Item 2.02 and the attached exhibit shall not be deemed "filed" for purposes of Section 18 of the Securities Exchange Act of 1934.
Investor Verification Checklist
- Review the full text of the press release (Exhibit 99.1) for specific Q3 2016 revenue and earnings figures.
- Verify year-over-year and quarter-over-quarter growth rates not present in this summary.
- Check for any forward-looking statements or guidance provided in the press release.
- Confirm the status of the Company's liquidity and debt obligations as detailed in the full financial report.